RecruitingEarly Phase 1NCT06205342

Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

STEMCAP-1: Safety and Efficacy of Mesenchymal Stem Cells Associated With Chronic Pancreatitis Pain

Sponsor

Medical University of South Carolina

Enrollment

48 participants

Start Date

Jul 17, 2024

Study Type

INTERVENTIONAL

Conditions

Chronic Pain Chronic Pancreatitis

Summary

This protocol aims to test whether an infusion of allogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs) can reduce pain associated with chronic pancreatitis (CP) and explore potential mechanisms of MSC action.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Mesenchymal Stem Cells and Other: Placebo for people with chronic pain and chronic pancreatitis. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.